Hold onto your hats, because Saroja Pharma Industries India is gearing up for a big financial leap! The company is all set to launch its very own Initial Public Offering (IPO) on August 31. Curious to know what's in store? Let's dive in and explore this exciting move.
Big Dreams, Big Bucks: The IPO Debut
Saroja Pharma Industries India has some big goals in mind – they're looking to raise a cool Rs 9.11 crore through their IPO. This move speaks volumes – it's like their way of announcing, "Hello world, we're set for growth!" They're issuing 10,84,800 new equity shares to make the vision true. And guess what? 54,400 of these shares (worth Rs 45.69 lakh) are especially set aside for the market maker.
Cracking the Numbers: Post-Issue Equity and Reserved Shares
When it comes to the grand picture, the IPO will make up 26.98 percent of the post-issue paid-up equity. To make sure everyone gets a shot, Saroja Pharma is reserving half of the net issue (that's 10,30,400 shares) for retail investors. The other half? Well, it's for the high net-worth individuals whose applications are worth more than Rs 2 lakh.
Jumping In: IPO Entry Made Easy
Thinking of jumping into this IPO adventure? You can start with as few as 1,600 equity shares, and then you can invest in blocks of 1,600 shares. So, for retail investors, that's a chance to get in with a package worth Rs 1,34,400. It's all about making it accessible for everyone.
Investing in Growth
Saroja Pharma has its sights set on expansion. They're planning to dive into API (active pharmaceutical ingredient) manufacturing. To do this, they're setting up an API manufacturing unit, spending about Rs 7.05 crore. And that's not all – they're also putting some money into repaying debts (Rs 1.75 crore) and covering the costs of the IPO process (Rs 31.35 lakh).
From Medicines to the World
Saroja Pharma isn't just in the business of medicines; they're also in the business of spreading their reach. They're all about marketing, trading, and distributing a range of pharmaceutical products. And guess what? They're not just in India – they've got their presence felt in countries like the UK, Jordan, Australia, and even Kenya!
Growing Beyond Limits: A New Manufacturing Unit
Looking ahead, Saroja Pharma is getting ready to create anthelmintics human tropical and veterinary medicine. For this, they're setting up a fancy manufacturing unit in Nashik, Maharashtra. It's a big move, and it's costing them about Rs 23 crore.
Save the Date: September 13
The IPO excitement doesn't end with its launch – the listing of Saroja Pharma's shares is set to happen on September 13. It's like a new chapter starting on the National Stock Exchange (NSE).
Guiding the IPO Journey
Behind the scenes, Swastika Investmart is the one steering the ship as the merchant banker for the issue. And Kfin Technologies? They're the ones taking care of all the registration stuff.
With Saroja Pharma's IPO on the horizon, the world of finance is getting a shake-up. And you? You've got the chance to be part of the action and witness a company's journey towards growth and success.